Oncotarget · 2016 · 53 citations · 42 references
Life SciencesHematologyOncologyApoptosisCell SignalingMolecular OncologyApoptosis In CancerApoptosis RegulationApoptotic SignalingCell DeathIntrinsic Apoptotic PathwayAcute Myeloid Leukemia BiologyApoptosis Signaling In CancerApoptosis Signaling RegulationApoptotic Signaling In CancerCancer Cell Apoptosis
// Valentina Salvestrini 1 , Stefania Orecchioni 2 , Giovanna Talarico 2 , Francesca Reggiani 2 , Cristina Mazzetti 3 , Francesco Bertolini 2 , Elisa Orioli 4 , Elena Adinolfi 4 , Francesco Di Virgilio 4 , Annalisa Pezzi 1 , Michele Cavo 1 , Roberto M Lemoli 5, * , Antonio Curti 1, * 1 Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Bologna, Italy 2 European Institute of Oncology, Milan, Italy 3 Department Biomedical and Neuromotor Sciences, University of Bologna, Bologna, Italy 4 Department of Morphology, Surgery and Experimental Medicine, University of Ferrara, Ferrara, Italy 5 Clinic of Hematology, Department of Internal Medicine (DiMI), University of Genoa, Genoa, Italy * These authors are contributed equally to this work Correspondence to: Valentina Salvestrini, email: valentin.salvestrin2@unibo.it Keywords: acute myeloid leukemia (AML), leukemic stem cell (LSC), P2X7R, ATP, apoptosis Received: May 24, 2016 Accepted: September 25, 2016 Published: December 13, 2016 ABSTRACT Recent studies have shown that high ATP levels exhibit direct cytotoxic effects on several cancer cells types. Among the receptors engaged by ATP, P2X7R is the most consistently expressed by tumors. P2X7R is an ATP-gated ion channel that could drive the opening of a non-selective pore, triggering cell-death signal. We previously demonstrated that acute myeloid leukemia (AML) cells express high level of P2X7R. Here, we show that P2X7R activation with high dose ATP induces AML blast cells apoptosis. Moreover, P2X7R is also expressed on leukemic stem/progenitor cells (LSCs) which are sensitive to ATP-mediated cytotoxicity. Conversely, this cytotoxic effect was not observed on normal hematopoietic stem/progenitor cells (HSCs). Notably, the antileukemic activity of ATP was also observed in presence of bone marrow stromal cells and its addition to the culture medium enhanced cytosine arabinoside cytotoxicity despite stroma-induced chemoresistance. Xenotransplant experiments confirmed ATP antineoplastic activity in vivo . Overall, our results demonstrate that P2X7R stimulation by ATP induced a therapeutic response in AML at the LSC level while the normal stem cell compartment was not affected. These results provide evidence that ATP would be promising for developing innovative therapy for AML.
42
Stromal cells prevent apoptosis of AML cells by up-regulation of anti-apoptotic proteins
Marina Konopleva, Sergej Konoplev, Wei Hu et al. · Leukemia · 2002 · 386 citations
Expression of P2X7 Receptor Increases <i>In Vivo</i> Tumor Growth
Elena Adinolfi, Lizzia Raffaghello, Anna Lisa Giuliani et al. · Cancer Research · 2012 · 348 citations · Full text
Medicine, Oncology, Pharmacology +17
Purines, Purinergic Receptors, and Cancer
Cancer Research · 2012 · 291 citations
Autocrine regulation of T‐cell activation by ATP release and P2X <sub>7</sub> receptors
Linda Yip, Tobias Woehrle, Ross Corriden et al. · The FASEB Journal · 2009 · 280 citations · Full text